The Role of Cancer Stem Cells (CD133) in Malignant Gliomas
Malignant gliomas, particularly glioblastoma multiforme (GBM) tumors, are very difficult to treat by conventional approaches. Although most of the tumor mass can be removed by surgical resection, radiotherapy, and chemotherapy, it eventually recurs. There is growing evidence that cancer stem cells (...
Main Authors: | Der-Yang Cho, Shinn-Zong Lin, Wen-Kuang Yang M.D., Ph.D., Den-Mei Hsu, Hung-Lin Lin, Han-Chung Lee, Wen-Yeun Lee, Shao-Chih Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-02-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368910X532774 |
Similar Items
-
Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant Gliomas
by: Der-Yang Cho, et al.
Published: (2009-09-01) -
Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.
by: Chih-Sin Hsu, et al.
Published: (2013-01-01) -
CD133 is a marker of bioenergetic stress in human glioma.
by: Corinne E Griguer, et al.
Published: (2008-01-01) -
Study of interaction between extracellular matrix proteins and receptors of CD133+ stem cells and CD133– differentiated glioma cells
by: V. E. Shevchenko, et al.
Published: (2019-04-01) -
Prominin 1/CD133 endothelium sustains growth of proneural glioma.
by: Bi-Sen Ding, et al.
Published: (2013-01-01)